These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1965908)

  • 1. The use of rat Leydig tumor (R2C) and human hepatoma (HEPG2) cells to evaluate potential inhibitors of rat and human steroid aromatase.
    Doody KM; Murry BA; Mason JI
    J Enzyme Inhib; 1990; 4(2):153-8. PubMed ID: 1965908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Leydig tumor cell steroidogenesis by 10-propargylestr-4-ene-3,17-dione, an irreversible aromatase inhibitor.
    Zimniski SJ; Brandt ME; Melner MH; Covey DF; Puett D
    Cancer Res; 1985 Oct; 45(10):4883-9. PubMed ID: 4027975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of in vivo administration of 10-propargylestr-4-ene-3,17-dione on rat ovarian aromatase and estrogen levels.
    Brandt ME; Covey DF; Zimniski SJ
    J Enzyme Inhib; 1990; 4(2):143-52. PubMed ID: 2098521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibition of human prostatic aromatase activity by imidazole drugs including ketoconazole and 4-hydroxyandrostenedione.
    Ayub M; Levell MJ
    Biochem Pharmacol; 1990 Oct; 40(7):1569-75. PubMed ID: 2222512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imidazole antimycotics: selective inhibitors of steroid aromatization and progesterone hydroxylation.
    Mason JI; Carr BR; Murry BA
    Steroids; 1987; 50(1-3):179-89. PubMed ID: 3504059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of aromatase activity and of endocrine-responsive tumor growth by 10-propargylestr-4-ene-3, 17-dione and its 17-propionate derivative.
    Zimniski SJ; Brandt ME; Covey DF; Puett D
    Steroids; 1987; 50(1-3):135-46. PubMed ID: 3504057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 4-hydroxyandrostenedione on murine Leydig tumor cell steroidogenesis.
    Zimniski SJ; Brandt ME; Melner MH; Brodie AM; Puett D
    Cancer Res; 1991 Jul; 51(14):3663-8. PubMed ID: 2065323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of growth and appearance of estrogen-dependent rat mammary tumors by 10-propargylestr-4-ene-3,17-dione, an aromatase inhibitor.
    Zimniski SJ; Brandt ME; Covey DF; Puett D
    Breast Cancer Res Treat; 1993; 26(1):15-21. PubMed ID: 8400320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aromatase and other inhibitors in breast and prostatic cancer.
    Brodie AM; Banks PK; Inkster SE; Son C; Koos RD
    J Steroid Biochem Mol Biol; 1990 Dec; 37(6):1043-8. PubMed ID: 2285580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aromatase inhibition and experimental antitumor activity of FCE 24304, MDL 18962 and SH 489.
    di Salle E; Briatico G; Giudici D; Ornati G; Zaccheo T
    J Steroid Biochem; 1989; 34(1-6):431-4. PubMed ID: 2516584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of pregnant mare's serum gonadotropin-stimulated rat ovarian aromatase and its inhibition by 10-propargylestr-4-ene-3,17-dione.
    Brandt ME; Puett D; Covey DF; Zimniski SJ
    J Steroid Biochem; 1988 Sep; 31(3):317-24. PubMed ID: 3419162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships of the inhibition of human placental aromatase by imidazole drugs including ketoconazole.
    Ayub M; Levell MJ
    J Steroid Biochem; 1988 Jul; 31(1):65-72. PubMed ID: 3398530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human trophoblast xenografts in athymic mice: a model for peripheral aromatization.
    Johnston JO; Wright CL; Shumaker RC
    J Steroid Biochem; 1989 Oct; 33(4A):521-9. PubMed ID: 2811362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative studies of aromatase inhibitors in cultured human breast cancer cells.
    MacIndoe JH; Woods GR; Etre LA; Covey DF
    Cancer Res; 1982 Aug; 42(8 Suppl):3378s-3381s. PubMed ID: 7083203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 10-(2-propynyl)-estr-4-ene-3,17-dione (MDL 18,962)--a mechanism-based irreversible inhibitor of aromatase--in cultured human foreskin fibroblasts.
    Kruter RH; Berkovitz GD; Migeon CJ; Brown TR
    J Steroid Biochem; 1987 Aug; 28(2):139-45. PubMed ID: 3626551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme inactivation by potential metabolites of an aromatase-activated inhibitor (MDL 18,962).
    Johnston JO; Wright CL; Holbert GW; Benson HD
    J Enzyme Inhib; 1990; 4(2):137-42. PubMed ID: 2098520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equine cytochrome P450 aromatase exhibits an estrogen 2-hydroxylase activity in vitro.
    Almadhidi J; Moslemi S; Drosdowsky MA; Séralini GE
    J Steroid Biochem Mol Biol; 1996 Sep; 59(1):55-61. PubMed ID: 9009238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of aromatase inhibitors on estrogen 2-hydroxylase in rat liver.
    Purba HS; King EJ; Richert P; Bhatnagar AS
    J Steroid Biochem Mol Biol; 1994 Feb; 48(2-3):215-9. PubMed ID: 8142297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of human H295R and rat R2C cell lines as in vitro screening tools for effects on aromatase.
    Heneweer M; van den Berg M; Sanderson JT
    Toxicol Lett; 2004 Jan; 146(2):183-94. PubMed ID: 14643970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of aromatase inhibitor 4-hydroxyandrostenedione on steroid receptors in hormone-dependent tissues of the rat.
    Zhou JL; Brodie A
    J Steroid Biochem Mol Biol; 1995 Jan; 52(1):71-6. PubMed ID: 7857875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.